A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
City of Hope Medical Center
National Institutes of Health Clinical Center (CC)
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Janssen Research & Development, LLC
The General Hospital of Western Theater Command
Affiliated Hospital to Academy of Military Medical Sciences
Gilead Sciences
M.D. Anderson Cancer Center
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
European Myeloma Network B.V.
Masonic Cancer Center, University of Minnesota
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
University of California, San Francisco
Medical College of Wisconsin
Celgene
National Institutes of Health Clinical Center (CC)
Affiliated Hospital to Academy of Military Medical Sciences
Massachusetts General Hospital
University of California, San Francisco
Dartmouth-Hitchcock Medical Center
Essen Biotech
M.D. Anderson Cancer Center
Senti Biosciences
Juno Therapeutics, a Subsidiary of Celgene
Mayo Clinic
Medical College of Wisconsin
M.D. Anderson Cancer Center
Fate Therapeutics
Thomas Jefferson University
Northside Hospital, Inc.
University of Rochester
National Institutes of Health Clinical Center (CC)
Caribou Biosciences, Inc.
Case Comprehensive Cancer Center
Weill Medical College of Cornell University
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
University of Pennsylvania
Indapta Therapeutics, INC.
Thomas Jefferson University
Cartesian Therapeutics
Janssen Scientific Affairs, LLC
Thomas Jefferson University
Memorial Sloan Kettering Cancer Center
Fred Hutchinson Cancer Center
Cedars-Sinai Medical Center